GCMG
GCM Grosvenor Inc
$
13.000
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
13.070
Open
13.070
VWAP
12.95
Vol
475.13K
Mkt Cap
2.53B
Low
12.870
Amount
6.15M
EV/EBITDA(TTM)
24.52
Total Shares
44.22M
EV
2.82B
EV/OCF(TTM)
15.49
P/S(TTM)
4.72
GCM Grosvenor Inc. is a global alternative asset management solutions provider with assets under management across private equity, infrastructure, real estate, credit, and absolute return investment strategies. The Company invests on a primary basis and through direct-oriented strategies, which it defines as secondaries, co-investments, direct investments and seed investments. It operates customized separate accounts and commingled funds. The Company collaborates with its clients to invest on their behalf across the private and public markets, either through portfolios customized to meet a client’s specific objectives or through specialized commingled funds that are developed to meet broad market demands for strategies and risk-return objectives. Its clients include large global institutional investors who rely on its investment expertise and differentiated investment access to navigate the alternatives market, but also include a growing individual investor client base.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
127.03M
+3.34%
0.174
+8.75%
157.10M
-4.94%
0.244
-9.63%
132.30M
+5.13%
0.177
-1.85%
Estimates Revision
The market is revising No Change the revenue expectations for GCM Grosvenor Inc. (GCMG) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 3.59%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+3.59%
In Past 3 Month
5 Analyst Rating
0Wall Street analysts forecast GCMG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GCMG is 14.88 USD with a low forecast of 13.00 USD and a high forecast of 19.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
2 Hold
0 Sell
Moderate Buy
0Current: 13.000
Low
13.00
Averages
14.88
High
19.00
0Current: 13.000
Low
13.00
Averages
14.88
High
19.00
Piper Sandler
Crispin Love
Overweight
maintain
$15
2025-08-08
New
Reason
Piper Sandler
Crispin Love
Price Target
$15
2025-08-08
New
maintain
Overweight
Reason
Piper Sandler analyst Crispin Love raised the firm's price target on GCM Grosvenor to $15 from $14.50 and keeps an Overweight rating on the shares. The firm notes shares were up following reporting Q2 results. On a core earnings and FRE basis, the quarter was slightly better than expectations and fundraising continued to be strong similar to what the firm has seen from other alternative asset managers.
Oppenheimer
Oppenheimer
Outperform
maintain
$19 -> $20
2025-08-08
New
Reason
Oppenheimer
Oppenheimer
Price Target
$19 -> $20
2025-08-08
New
maintain
Outperform
Reason
Oppenheimer raised the firm's price target on GCM Grosvenor to $20 from $19 and keeps an Outperform rating on the shares following quarterly results. On the revenue side, private markets were slightly lower than expected and absolute return strategies were slightly higher, with the net of the two fractionally higher while expenses were fractionally lower and this drove a 2% beat in fee-related earnings.
Piper Sandler
Crispin Love
Buy
Maintains
$16 → $15
2025-04-08
Reason
Piper Sandler
Crispin Love
Price Target
$16 → $15
2025-04-08
Maintains
Buy
Reason
Piper Sandler lowered the firm's price target on GCM Grosvenor to $14.50 from $16 and keeps an Overweight rating on the shares. The firm notes asset managers have underperformed financials and the broader market in 2025-to-date, and in recent days, following outperformance in 2024. Sentiment and the outlook have shifted dramatically in what was initially believed to be an environment primed for alternative asset managers for deal activity and realizations following the Trump election to one that is now grappling with tariffs, a potential recession and a capital markets window slamming shut, Piper argues. Unfortunately, given the fluidity of the current environment "we will likely finish 1Q25 earnings season with more questions than answers with uncertainty in current policy and impacts to the macro and asset managers unclear," Piper says.
UBS
Adam Beatty
Hold
Maintains
$13 → $14
2025-02-19
Reason
UBS
Adam Beatty
Price Target
$13 → $14
2025-02-19
Maintains
Hold
Reason
Piper Sandler
Crispin Love
Hold
to
Buy
Upgrades
$13 → $14
2024-12-23
Reason
Piper Sandler
Crispin Love
Price Target
$13 → $14
2024-12-23
Upgrades
Hold
to
Buy
Reason
Piper Sandler upgraded GCM Grosvenor to Overweight from Neutral with a price target of $14, up from $12.50. There has been a "noticeable shift in sentiment" in the alternatives space in recent months and Piper does not believe the discounted valuation that GCM Grosvenor is trading at is warranted, the analyst tells investors in a research note. The firm expects momentum in fundraising, growth in direct oriented investments, and a pickup in deal activity to drive carried interest and performance revenues for GCM. The Federal Reserve rate cutting cycle, less regulation, a pro-growth and pro-business administration, and pent-up demand are all areas that could lead to a pickup in transactions which is positive for GCM, contends the firm.
Oppenheimer
Chris Kotowski
Buy
Maintains
$18 → $20
2024-12-12
Reason
Oppenheimer
Chris Kotowski
Price Target
$18 → $20
2024-12-12
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for GCM Grosvenor Inc (GCMG.O) is 16.38, compared to its 5-year average forward P/E of 16.13. For a more detailed relative valuation and DCF analysis to assess GCM Grosvenor Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
16.13
Current PE
16.38
Overvalued PE
19.73
Undervalued PE
12.52
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
4.14
Current EV/EBITDA
4.53
Overvalued EV/EBITDA
5.35
Undervalued EV/EBITDA
2.93
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Overvalued
5Y Average PS
0.91
Current PS
1.23
Overvalued PS
1.09
Undervalued PS
0.73
Financials
Annual
Quarterly
FY2025Q2
YoY :
+2.31%
119.66M
Total Revenue
FY2025Q2
YoY :
-18.56%
20.87M
Operating Profit
FY2025Q2
YoY :
+207.78%
39.89M
Net Income after Tax
FY2025Q2
YoY :
+25.00%
0.05
EPS - Diluted
FY2025Q2
YoY :
+218.25%
40.76M
Free Cash Flow
FY2025Q2
YoY :
0.00%
100.00
Gross Profit Margin - %
FY2025Q2
YoY :
+49.47%
32.24
FCF Margin - %
FY2025Q2
YoY :
+200.90%
33.34
Net Margin - %
FY2025Q2
N/A
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 131977.58% over the last month.
Sold
0-3
Months
232.4M
USD
2
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
53.6K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
366.9K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 131977.58% over the last month.
Sold
0-3
Months
232.4M
USD
2
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
53.6K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
GCMG News & Events
Events Timeline
2025-08-07 (ET)
2025-08-07
08:04:19
GCM Grosvenor reports Q2 adjusted EPS 16c, consensus 15c
2025-07-16 (ET)
2025-07-16
09:09:16
GCM Grosvenor, Wilshire Indexs launch Private Markets Infrastructure Index
2025-06-03 (ET)
2025-06-03
08:15:03
Proteus MHP announces $60M equity commitment from GCM Grosvenor
Sign Up For More Events
Sign Up For More Events
News
9.5
08-07NASDAQ.COMGCM Grosvenor (GCMG) Q2 2025 Earnings Transcript
9.5
07-24NewsfilterGCM Grosvenor to Announce Second Quarter 2025 Financial Results and Host Investor Conference Call on August 7, 2025
7.5
07-16NewsfilterWilshire Indexes and GCM Grosvenor Launch Private Market Infrastructure Index, Laying Foundation for Broader Strategic Alliance
Sign Up For More News
People Also Watch
WULF
Terawulf Inc
5.460
USD
+4.20%
ICFI
ICF International Inc
99.660
USD
+4.21%
ADUS
Addus Homecare Corp
116.330
USD
+2.89%
SPNT
Siriuspoint Ltd
18.760
USD
+1.57%
MTX
Minerals Technologies Inc
63.140
USD
+3.49%
FBK
FB Financial Corp
51.080
USD
+4.31%
HNI
HNI Corp
45.150
USD
+1.21%
RPD
Rapid7 Inc
21.320
USD
+5.86%
MPW
Medical Properties Trust Inc
4.130
USD
+3.77%
ARWR
Arrowhead Pharmaceuticals Inc
19.990
USD
+12.30%
FAQ
What is GCM Grosvenor Inc (GCMG) stock price today?
The current price of GCMG is 13 USD — it has decreased -0.23 % in the last trading day.
What is GCM Grosvenor Inc (GCMG)'s business?
What is the price predicton of GCMG Stock?
What is GCM Grosvenor Inc (GCMG)'s revenue for the last quarter?
What is GCM Grosvenor Inc (GCMG)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for GCM Grosvenor Inc (GCMG)'s fundamentals?
How many employees does GCM Grosvenor Inc (GCMG). have?